Cognition, ADHD Symptoms, and Functional Impairment in Children and Adolescents With Neurofibromatosis Type 1

被引:39
|
作者
Payne, Jonathan M. [1 ,2 ]
Haebich, Kristina M. [1 ]
MacKenzie, Rachel [5 ]
Walsh, Karin S. [6 ]
Hearps, Stephen J. C. [1 ]
Coghill, David [1 ,3 ]
Barton, Belinda [11 ,13 ]
Pride, Natalie A. [12 ,14 ]
Ullrich, Nicole J. [15 ]
Tonsgard, James H. [16 ]
Viskochil, David [17 ]
Schorry, Elizabeth K. [18 ]
Klesse, Laura [19 ]
Fisher, Michael J. [20 ,21 ,22 ]
Gutmann, David H. [23 ,24 ]
Rosser, Tena [25 ]
Packer, Roger J. [7 ,8 ,9 ,10 ]
Korf, Bruce [26 ,27 ,28 ]
Acosta, Maria T. [9 ]
Bellgrove, Mark A. [29 ,30 ]
North, Kathryn N. [1 ,4 ]
机构
[1] Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Dept Pediat, Parkville, Vic, Australia
[3] Univ Melbourne, Dept Pediat, Dev Mental Hlth, Parkville, Vic, Australia
[4] Univ Melbourne, Child Hlth Res, Parkville, Vic, Australia
[5] La Trobe Univ, Bundoora, Vic, Australia
[6] Childrens Natl Hlth Syst, Div Pediat Neuropsychol, Washington, DC USA
[7] Childrens Natl Hlth Syst, Ctr Neurosci & Behav Med, Washington, DC USA
[8] Childrens Natl Hlth Syst, Neurofibromatosis, Washington, DC USA
[9] Childrens Natl Hlth Syst, Gilbert Neurofibromatosis Inst, Washington, DC USA
[10] Childrens Natl Hlth Syst, Brain Tumor Inst, Washington, DC USA
[11] Childrens Hosp Westmead, Childrens Hosp Educ Res Inst, Westmead, NSW, Australia
[12] Childrens Hosp Westmead, Clin Genet & Kids Neurosci Res Ctr, Neurocognit Team, Neuropsychol, Westmead, NSW, Australia
[13] Univ Sydney, Fac Med, Discipline Pediat & Child Hlth, Sydney, NSW, Australia
[14] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
[15] Boston Childrens Hosp, Boston, MA USA
[16] Univ Chicago Med, Comer Childrens Hosp, Chicago, IL USA
[17] Univ Utah, NF Clin, Salt Lake City, UT USA
[18] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[19] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA
[20] Childrens Hosp Philadelphia, Sect Neuooncol, Philadelphia, PA 19104 USA
[21] Childrens Hosp Philadelphia, Neurooncol Fellowship Program, Philadelphia, PA 19104 USA
[22] Childrens Hosp Philadelphia, Neurofibromatosis Program, Philadelphia, PA 19104 USA
[23] Washington Univ, Sch Med, Neurol Neurosurg Pediat & Genet, St Louis, MO USA
[24] Washington Univ, Sch Med, Res, St Louis, MO USA
[25] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
[26] Univ Alabama Birmingham, Med Genet, Birmingham, AL USA
[27] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA
[28] Univ Alabama Birmingham, Heflin Ctr Genom Sci, Birmingham, AL USA
[29] Monash Univ, Sch Psychol Sci, Cognit Neurosci, Clayton, Vic, Australia
[30] Monash Univ, Sch Psychol Sci, Multidisciplinary Team Studying Biol Basis Attent, Clayton, Vic, Australia
基金
英国医学研究理事会;
关键词
ADHD; neurofibromatosis type 1; cognition; executive function; functional impairment; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; QUALITY-OF-LIFE; EXECUTIVE FUNCTION; DYSFUNCTION; LOVASTATIN; VALIDITY; DEFICITS; MODEL; BOYS;
D O I
10.1177/1087054719894384
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Objective: We examined the contribution of attention and executive cognitive processes to ADHD symptomatology in NF1, as well as the relationships between cognition and ADHD symptoms with functional outcomes. Methods: The study sample consisted of 141 children and adolescents with NF1. Children were administered neuropsychological tests that assessed attention and executive function, from which latent cognitive variables were derived. ADHD symptomatology, adaptive skills, and quality of life (QoL) were assessed using parent-rated questionnaires. Path analyses were conducted to test relationships among cognitive functioning, ADHD symptomatology, and functional outcomes. Results: Significant deficits were observed on all outcome variables. Cognitive variables did not predict ADHD symptomatology. Neither did they predict functional outcomes. However, elevated ADHD symptomatology significantly predicted functional outcomes. Conclusion: Irrespective of cognitive deficits, elevated ADHD symptoms in children with NF1 negatively impact daily functioning and emphasize the importance of interventions aimed at minimizing ADHD symptoms in NF1.
引用
收藏
页码:1177 / 1186
页数:10
相关论文
共 50 条
  • [21] Understanding Nonliteral Language Abilities in Children With Neurofibromatosis Type 1
    Haebich, Kristina M.
    Pride, Natalie A.
    Collins, Alana
    Porter, Melanie
    Anderson, Vicki
    Maier, Alice
    Darke, Hayley
    North, Kathryn N.
    Payne, Jonathan M.
    NEUROPSYCHOLOGY, 2023, 37 (08) : 872 - 882
  • [22] Executive functioning, ADHD symptoms and resting state functional connectivity in children with perinatal stroke
    Meghji, Suraya
    Hilderley, Alicia J.
    Murias, Kara
    Brooks, Brian L.
    Andersen, John
    Fehlings, Darcy
    Dlamini, Nomazulu
    Kirton, Adam
    Carlson, Helen L.
    BRAIN IMAGING AND BEHAVIOR, 2024, 18 (02) : 263 - 278
  • [23] A rating measure of ADHD-related neuropsychological impairment in children and adolescents: Data from the Cognition and Motivation in Everyday Life (CAMEL) Scale from population and clinical samples
    Van Liefferinge, Dagmar
    Sonuga-Barke, Edmund
    Van Broeck, Nady
    Van Der Oord, Saskia
    Lemiere, Jurgen
    Danckaerts, Marina
    CHILD NEUROPSYCHOLOGY, 2017, 23 (04) : 483 - 501
  • [24] Justice and rejection sensitivity in children and adolescents with ADHD symptoms
    Bondue, Rebecca
    Esser, Guenter
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2015, 24 (02) : 185 - 198
  • [25] Aging and Pubertal Development Differentially Predict Symptoms of ADHD, Depression, and Impairment in Children and Adolescents: An Eight-Year Longitudinal Study
    Eng, Ashley G.
    Phan, Jenny M.
    Shirtcliff, Elizabeth A.
    Eisenlohr-Moul, Tory A.
    Goh, Patrick K.
    Martel, Michelle M.
    RESEARCH ON CHILD AND ADOLESCENT PSYCHOPATHOLOGY, 2023, 51 (06): : 819 - 832
  • [26] Psychometric properties of the Weiss Functional Impairment Rating Scale parent and self-reports in a Norwegian clinical sample of adolescents treated for ADHD
    Haugan, Anne-Lise Juul
    Sund, Anne Mari
    Thomsen, Per Hove
    Lydersen, Stian
    Novik, Torunn Stene
    NORDIC JOURNAL OF PSYCHIATRY, 2021, 75 (01) : 63 - 72
  • [27] The Impact of Internalizing Symptoms on Impairment for Children With ADHD: A Strength-Based Perspective
    Bethune, Sarah C.
    Rogers, Maria A.
    Smith, David
    Whitley, Jess
    Hone, Michael
    McBrearty, Natasha
    JOURNAL OF ATTENTION DISORDERS, 2023, 27 (01) : 26 - 37
  • [28] Reading Comprehension Impairment in Children With Neurofibromatosis Type 1 (NF1): The Need of Multimodal Assessment of Attention
    Biotteau, Maelle
    Tournay, Elodie
    Baudou, Eloise
    Destarac, Sandrine
    Iannuzzi, Stephanie
    Faure-Marie, Nathalie
    Castelnau, Pierre
    Schweitzer, Elisabeth
    Rodriguez, Diana
    Kemlin, Isabelle
    Dorison, Nathalie
    Rivier, Francois
    Carneiro, Maryline
    Preclaire, Elodie
    Barbarot, Sebastien
    Lauwers-Cances, Valerie
    Chaix, Yves
    JOURNAL OF CHILD NEUROLOGY, 2021, 36 (08) : 625 - 634
  • [29] Neurodevelopmental disorders in children with neurofibromatosis type 1
    Vogel, Alecia C.
    Gutmann, David H.
    Morris, Stephanie M.
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2017, 59 (11): : 1112 - 1116
  • [30] Neurological comorbidity in children with neurofibromatosis type 1
    Hirabaru, Keiko
    Matsuo, Muneaki
    PEDIATRICS INTERNATIONAL, 2018, 60 (01) : 70 - 75